Drug Channels

AUGUST 1, 2023

In my most recent video webinar , I explored how plans and PBMs are turning to novel—and highly controversial—benefit design tools that access manufacturers’ patient support spending: copay accumulators, maximizers, and alternative funding programs.

Manufacturing 78

Manufacturing Drugs Marketing 78

Drug Discovery World

FEBRUARY 5, 2024

Ian Scanlon will discuss bottlenecks in advanced therapeutic delivery and how novel technologies can improve patient access and deliver sustainable processes. Mark Treherne will talk about advanced therapies and the development of RNA gene therapy for aggressive cancers which is being carried out at Spliceor.

Gene Therapy 52

Gene Therapy Gene Marketing RNA 52

Pharmaceutical Technology

FEBRUARY 24, 2023

The overhaul will address drug marketing exclusivity length, pricing, patient access, innovation incentives, antimicrobial resistance, clinical trials, supply chain security and shortages, and environmental impact. The EU is planning a sweeping revision of its pharma legislation in March, the largest change in 20 years.

Regulation 162

Regulation Clinical Trials Clinical Trials Medicine 162

Drug Discovery World

FEBRUARY 13, 2024

In this webinar, hosted by DDW and sponsored by Astrea Bioseparations, you will learn about how market growth can be sustained to maximise on opportunities in cell and gene therapy (CGT). The post Cell & gene therapies: How can market growth be sustained to maximise on opportunities?

Gene Therapy 52

Gene Therapy Gene Marketing RNA 52

Drug Channels

OCTOBER 12, 2023

He explains how pharma brand teams and hub program managers can lessen the impact of accumulators and maximizers on patients’ access and adherence. Read on for Sam’s insights.

Branding 82

Branding Drugs Marketing Development 82

Drug Channels

DECEMBER 15, 2022

This week, I’m rerunning some popular posts while I prepare for tomorrow’s live video webinar: Drug Channels Outlook 2023. The research was sponsored by the Association for Accessible Medicines (AAM). There’s a lot to unpack about the growing discount card market. Link below.) d/b/a Drug Channels Institute.

Marketing 88

Marketing Medicine Drugs Research 88

Drug Channels

OCTOBER 5, 2023

In my most recent video webinar , I explored how plans and PBMs are turning to novel—and highly controversial—benefit design tools that access manufacturers’ patient support spending: copay accumulators, maximizers, and alternative funding programs. Details and industry reactions here.

Manufacturing 77

Manufacturing Drugs Marketing 77

Pharmaceutical Technology

OCTOBER 26, 2022

On October 6, in a GlobalData webinar, experts tried to answer the question ‘ Is Pharma at an ESG turning point?’ , revealing a multitude of diverse strategies for pharmaceutical companies to remain conscious of their global impacts. Research presented at GlobalData’s webinar supported this data.

Clinical Trials 162

Clinical Trials Clinical Trials Trials Life Science 162

XTalks

MARCH 4, 2024

The US Food and Drug Administration (FDA) has granted marketing authorization to Virtual Incision’s MIRA Surgical System, recognized as the world’s first miniaturized robotic-assisted surgery (miniRAS) device. The device is authorized for use in adult colectomy (treatment of colon diseases) procedures.

Marketing 52

Marketing Compliance Development Drugs 52

XTalks

MAY 30, 2023

By now we all know how incredibly important webinars are for your marketing strategy, but there’s a big difference between an ordinary webinar and a fantastic, impactful one! So without further ado, let’s dive into how to best discover and understand your webinar’s target audience.

Sales 52

Sales Marketing Production Research 52

Drug Channels

SEPTEMBER 8, 2021

Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for his latest video webinar: Drug Channels Update: Buy-and-Bill Market Trends. This event is part of The Drug Channels 2021 Quarterly Video Webinar Series. The webinar will be 90 minutes to accommodate audience questions.

Marketing 74

Marketing Drugs Development Production 74

Drug Channels

JULY 5, 2022

Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new video webinar: Specialty Drugs Update: Trends, Controversies, and Outlook. This event is part of The Drug Channels 2022 Video Webinar Series. This event will be broadcast live on July 29, 2022 , from 12:00 p.m. to 1:30 p.m.

Drugs 85

Drugs Pharmacy Marketing 85

XTalks

NOVEMBER 28, 2023

Amazon’s One Medical platform streamlines the process of accessing essential healthcare services, spanning from preventive care to addressing immediate health concerns and effectively managing chronic conditions such as diabetes. Other Virtual Care Platforms Available in the Market Numerous virtual care platforms are available in the market.

Pharmacy 104

Pharmacy Allergies Licensing Licensing 104

Drug Channels

MARCH 27, 2023

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Discount Cards, Cost-Plus Pharmacies, and PBMs: Trends, Controversies, and Outlook. Patients get access to market prices that can be lower than their PBM’s contracted rate. Links below.

Pharmacy 79

Pharmacy Drugs Marketing Generic Drugs 79

XTalks

AUGUST 3, 2023

The funds will allow us to focus on sales and marketing efforts as we expand distribution across North America and continue our goal of making sustainable, delicious plant-based food widely accessible.” According to a report by Allied Market Research, the plant-based seafood market was valued at $42.1

Branding 97

Branding Protein Marketing Production 97

XTalks

JUNE 16, 2023

This FDA approval makes personalized medicine more expedient and accessible to a subgroup of patients battling metastatic colorectal cancer associated with a poor prognosis. With this FDA approval of FoundationOne Liquid CDx, physicians can access a cancer mutation profile more quickly and easily. billion in 2022 to $15.91

FDA Approval 97

FDA Approval Genome Genomics DNA 97

Drug Channels

MARCH 29, 2022

Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new video webinar: PBM Industry Update: Trends, Controversies, and Outlook. This event is part of The Drug Channels 2022 Video Webinar Series. Broadcast live on April 22, 2022 , from 12:00 p.m. to 1:30 p.m. WHAT YOU WILL LEARN.

Pharmacy 73

Pharmacy Drugs Marketing 73

XTalks

FEBRUARY 2, 2021

B2B marketers are preparing themselves for what lies ahead in 2021 after the fallout from the COVID-19 pandemic. . The widespread economic shutdown created a negative return on investment for marketers during the previous year. Remote access to live and on-demand online content has therefore become a necessity. .

Marketing 98

Marketing Branding Sales Production 98

XTalks

MARCH 7, 2024

This structured approach ensures that industry stakeholders have a thorough understanding of the requirements and procedures, promoting compliance and safety in the dietary supplement market. The importance of this guidance cannot be overstated.

Regulation 105

Regulation Manufacturing Compliance Marketing 105

Drug Channels

NOVEMBER 15, 2022

Patients get access to market prices that can be lower than their PBM’s contracted rate. I’ll cover what’s next for PBMs and discount cards during my upcoming live video webinar, Drug Channels Outlook 2023 , on December 16, 2022, from 12:00 p.m. Links below. to 1:30 p.m. Click here to learn more and sign up.

Pharmacy 88

Pharmacy Drugs Marketing Generic Drugs 88

XTalks

APRIL 18, 2024

However, Roche has several CSF tests on the market, which include assays in the company’s Elecsys line that are used in conjunction with PET in the diagnosis and monitoring of the disease. There are currently no FDA-authorized blood tests for detecting Alzheimer’s disease. The disease has an estimated $360 billion cost to the US economy.

Clinical Trials 52

Clinical Trials Clinical Trials In-Vitro Protein 52

XTalks

JULY 18, 2023

Traditional marketing focuses on pushing sales messages and highlighting the brand’s features and benefits, whereas brand journalism aims to provide valuable information, educate the audience and entertain them through compelling narratives.

Branding 98

Branding Marketing Sales Development 98

XTalks

JULY 7, 2023

Moreover, the study identified several distinguishing characteristics of POHs compared to private non-POHs in the same market. POHs were smaller in size, exhibited higher profitability, were more likely to be for-profit, non-teaching, non-critical access and located in metropolitan areas.

Regulation 98

Regulation Marketing Licensing Licensing 98

pharmaphorum

APRIL 12, 2022

In today’s competitive global market, pharmaceutical companies cannot afford to waste time or resources on strategies that do not fit patient needs or generate scripts. But how do you ensure you are making the right connections and ensuring all key stakeholders have access to tailored education around treatments?

Marketing 52

Marketing 52

Pharmaceutical Technology

NOVEMBER 2, 2022

Sometimes, this data can be helpful in a market access setting to inform or support pricing and reimbursement procedures. Throughout those initial years, the company’s dynamic team of medical advisors and market access experts established a large pan-European network of healthcare professionals. A fresh approach.

Medicine 130

Medicine Doctors Doctor Marketing 130

World of DTC Marketing

JANUARY 11, 2022

As HCPs get more digitally savvy, pharma marketers should understand that engaging physicians through channels and time of their preference with content relevant to the individual customer. is no more an option but a critical factor to ensure success for any multichannel marketing initiatives.

Pharma Companies 235

Pharma Companies Sales Marketing Clinical Trials 235

XTalks

JULY 21, 2023

These members now have access to the advanced Iris platform, offering specialized mental health care tailored for oncology patients, 24×7 symptom management and essential nutritional support. We are excited to offer expanded access to HealthPartners members.” RELATED: care.ai

Nurses 98

Nurses Doctors Doctor Clinical Trials 98

pharmaphorum

APRIL 1, 2022

However, while this dramatic shake-up of the UK Market Access environment aims to improve care for patients and providers for life science companies, this unfamiliar territory presents both opportunities and challenges. The post ICSs – an opportunity to improve Patient & Market Access at a local level appeared first on.

Marketing 98

Marketing Life Science Pharmacy Sales 98

XTalks

MARCH 6, 2023

The portfolio contains approximately forty-five commercial products, four products in the pipeline, and forty approved non-marketed products, many of which are generics focused on women’s health. The US has always been an important market for us,” said Chief Executive Officer of Dr. Reddy’s, Erez Israeli, in a statement.

Production 98

Production Branding Dermatology Hormones 98

Pharma Marketing Network

FEBRUARY 16, 2021

These companies had to make a quick turnaround and transfer all of their in-person information into digital materials that could be easily accessible online for their attendees. This includes putting together visuals (if necessary) and inviting key speakers to speak at your webinar who are specialized in the topic that you are discussing.

Marketing 98

Marketing Doctors Doctor 98

Drug Channels

AUGUST 13, 2021

Today’s guest post comes from Stacey Little, Senior Vice President of Business Development and Marketing at AssistRx. Stacey discusses how a patient support vendor can help specialty pharmacy patients attain prior authorizations and access critical therapies. Read on for Stacey’s insights. d/b/a Drug Channels Institute.

Branding 54

Branding Pharmacy Business Development Manufacturing 54

pharmaphorum

JUNE 21, 2022

Whether it’s the levelling up agenda, economics, social care and population health management and more, ICSs are front and centre of everything,” Steven Ferguson, head of Market Access UK and Ireland, IQVIA. The post ICSs: improving patient and market access at a local level appeared first on.

Marketing 52

Marketing Life Science 52

Drug Channels

JUNE 1, 2021

Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for his latest live video webinar: Drug Channels Update: 340B Controversies and Outlook. This event is part of The Drug Channels 2021 Quarterly Video Webinar Series. The webinar will be 90 minutes to accommodate audience questions.

Pharmacy 52

Pharmacy Drugs Manufacturing Marketing 52

World of DTC Marketing

NOVEMBER 9, 2021

Tighter access has put HCPs in the driving seat. They have been exposed to more convenient digital engagements and have many digital options for accessing what they need. Social media and webinar platforms have seen a massive increase in usage across the industry, and many cite them as an important engagement channel.

Branding 231

Branding Marketing Research Development 231

pharmaphorum

MARCH 1, 2022

Primary care sites require their own approach, but they can have great benefits for clinical trial recruitment, access to hard-to-reach patients, and more. The webinar will be held Thursday 24th March at 14:00 GMT / 15:00 CET. The webinar will be held Thursday 24th March at 14:00 GMT / 15:00 CET. The webinar will cover.

Clinical Research 96

Clinical Research Research Vaccination Vaccine 96

Drug Channels

NOVEMBER 29, 2022

In this issue: Mark Cuban schools Elon Musk on PBMs Market access lessons from Semglee Gen Z rejects the pharmacy career path A potent call for 340B transparency Plus, get ready to love the ‘90s again! Please join me for my upcoming live video webinar, Drug Channels Outlook 2023 , on December 16, 2022, from 12:00 p.m.

Pharmacy 73

Pharmacy Drugs Marketing 73

Drug Channels

JUNE 21, 2023

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: PBMs and the Battle Over Patient Support Funds: Accumulators, Maximizers, and Alternative Funding. Click here to see the original post from April 2023. Our latest data appear below.

Marketing 61

Marketing Branding Sales Pharmacy 61